Physician
Jung, Josephine
Jung, Josephine was paid $1.64M by Medicaid between May 2018 and Dec 2023, across 60 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 59% of everything it billed.
33Billing provider infoJUNG, JOSEPHINE
NEW HYDE PARK, NY 11040
NEW HYDE PARK, NY 11040
33aNPI1689663353assigned 10/17/2005
33bProvider typePediatrics Physician
28Total paid$1.64M
24GClaims51,346
24DCodes billed60
24AFirst – last monthMay 2018 – Dec 2023
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#198 of 1,983
Median peer was paid$17K
This provider vs. median97×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 208 | $13K | |
| 2019 | 6,000 | $179K | |
| 2020 | 12,268 | $322K | |
| 2021 | 12,262 | $391K | |
| 2022 | 12,446 | $456K | |
| 2023 | 8,162 | $282K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 59% | 10,362 | 8,204 | $964K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.9% | 790 | 714 | $113K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.7% | 3,771 | 3,743 | $94K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.5% | 820 | 820 | $91K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.3% | 803 | 801 | $88K |
| 92552 | 4.5% | 2,213 | 2,212 | $73K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.6% | 357 | 357 | $43K |
| 99402 | 2.0% | 3,572 | 3,467 | $34K | |
| 94060 | 1.2% | 359 | 295 | $20K | |
| 90461 | 1.1% | 718 | 715 | $19K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 185 | 172 | $18K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.1% | 160 | 160 | $18K |
48 more codes
| 99051 | <1% | 2,875 | $11K | |
| 96127 | <1% | 2,775 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 186 | $6K |
| 0072A | <1% | 115 | $5K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,448 | $5K |
| 0071A | <1% | 102 | $4K | |
| 99441 | <1% | 116 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 307 | $4K |
| 94644 | <1% | 100 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,744 | $3K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 25 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 28 | $2K |
| 96160 | <1% | 466 | $2K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 240 | $2K |
| 99383 | <1% | 12 | $1K | |
| 0124A | <1% | 26 | $1K | |
| S9470 | Nutritional counseling, dietitian visit | <1% | 3,096 | $994.21 |
| 99050 | <1% | 157 | $876.86 | |
| 69210 | <1% | 16 | $798.87 | |
| 81002 | <1% | 299 | $748.16 | |
| 99401 | <1% | 110 | $731.30 | |
| 83655 | <1% | 908 | $728.68 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 105 | $683.89 |
| 99173 | <1% | 1,712 | $643.97 | |
| 90686 | <1% | 1,180 | $562.92 | |
| 90670 | <1% | 65 | $500.64 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 143 | $199.86 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 1,626 | $149.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 14 | $148.86 |
| 90672 | <1% | 367 | $55.76 | |
| 90715 | <1% | 12 | $37.58 | |
| 94760 | <1% | 3,487 | $21.94 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 73 | $3.21 |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | <1% | 12 | $1.99 |
| 91312 | <1% | 22 | $0.28 | |
| 91307 | <1% | 88 | $0.19 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 287 | $0.00 |
| 3725F | 0% | 77 | $0.00 | |
| 94664 | 0% | 14 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 12 | $0.00 |
| 99072 | 0% | 109 | $0.00 | |
| 90651 | 0% | 12 | $0.00 | |
| 3008F | 0% | 1,504 | $0.00 | |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 99 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 12 | $0.00 |
| 1000F | 0% | 12 | $0.00 | |
| 1036F | 0% | 12 | $0.00 | |
| 90619 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.